Abstract
Diffuse parenchymal lung disease is a generic term including a variety of disorders characterized by accumulation/infiltration of extracellular substances, fluids, or cells in the structures of the secondary pulmonary lobule. Pathophysiology is different according to the large number of disorders grouped together. However five basic mechanisms may be considered: infections, malignancy, granulomatous inflammation, nongranulomatous inflammation/fibrosis, and finally alveolar stem cell exhaustion and bronchiolar proliferation/fibrosis. The clinical features may be helpful for diagnosis, but the imaging aspects are a keystone in the diagnostic workup. Invasive procedures are needed only in a minority although still significant number of cases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Colby TV, Carrington CB. Interstitial lung disease. In: Thurlbeck WM, Churg AM, editors. Pathology of the lung. New York: Thieme; 1995. p. 589–737.
Nagaishi C. Functional anatomy and histology of the lung. Baltimore: University Park Press; 1972. p. 26–41.
Martignoni G, Pea M, Righellin D, et al. Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors. Arch Pathol Lab Med. 2010;134:33–40.
Durham BH. Molecular characterization of the histiocytosis: neoplasia of dendritic and macrophages. Semin Cell Dev Biol. 2019;86:62–76.
Milne P, Bigley V, Bacon CM, et al. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim Chester disease in adults. Blood. 2017;130:167–75.
Korsten P, Tampa B, Konig MF, Nikiphorou E. Sarcoidosis and autoimmune diseases: differences, similarities and overlaps. Curr Opin Pulm Med. 2018;24:504–12.
Sood AK, Funkhouser W, Handly B, Weston B, Wu EY. Granulomatous-lymphocytic interstitial lung disease in 22q11.2 deletion syndrome: case report and literature review. Curr Allergy Asthma Rep. 2018;18:14.
Atzeni F, Gerardi MC, Barillaro G, Masala IF, Benucci M, Sarzi-Puttini P. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review. Expert Rev Clin Immunol. 2018;14:69–82.
Chilosi M, Caliò A, Rossi A, et al. Epithelial to mesenchymal transition-related proteins ZEB1, beta-catenin, and beta-tubulin III in idiopathic pulmonary fibrosis. Mod Pathol. 2017;30:26–36.
Chilosi M, Carloni A, Rossi A, Poletti V. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Transl Res. 2013;162:156–73.
Kaur A, Mathai SK, Schwartz DA. Genetics in idiopathic pulmonary fibrosis. Pathogenesis, prognosis and treatment. Front Med. 2017;4:154.
Hoffman TW, van Moorsel CHM, Borie R, Crestani B. Pulmonary phenotypes associated with genetic variation in telomere-related genes. Curr Opin Pulm Med. 2018;24:269–80.
Allen RJ, Porte J, Braybrooke R, et al. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. Lancet Respir Med. 2017;5:869–80.
Dal Piaz G. Computed tomography of diffuse lung diseases and solitary pulmonary nodules. In: Leslie KO, Wick MR, editors. Practical pulmonary pathology: a diagnostic approach. 3rd ed. Amsterdam: Elsevier; 2018. p. 35–98.
Cagle PT, Kerr KM. Pulmonary pathology. Berlin: Springer; 2018.
Costabel U, du Bois RM, Egan JJ, Herth F, Bolliger CT. Diffuse parenchymal lung disease. Basel: Karger; 2007.
Hetzel J, Maldonado F, Ravaglia C, et al. Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases. Expert statement from the cryobiopsy working group on safety and utility and a call for standardization of the procedure. Respiration. 2018;95:188–200.
Poletti V, Casoni GL, Gurioli C, Ryu JH, Tomassetti S. Lung cryobiopsies: a paradigm shift in diagnostic bronchoscopy? Respirology. 2014;19:645–54.
Ravaglia C, Wells AU, Tomassetti S, Gurioli C, Gurioli C, Dubini A, Cavazza A, Colby TV, Piciucchi S, Puglisi S, Bosi M, Poletti V. Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients. BMC Pulm Med. 2019;19(1):16.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Poletti, V. (2019). Diffuse Parenchymal Lung Disease: A Clinical Overview. In: Poletti, V. (eds) Transbronchial cryobiopsy in diffuse parenchymal lung disease. Springer, Cham. https://doi.org/10.1007/978-3-030-14891-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-14891-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-14890-4
Online ISBN: 978-3-030-14891-1
eBook Packages: MedicineMedicine (R0)